Aug. 1, 2019—Michael Savona, MD, has received a competitive grant to develop therapies for patients with myelodysplastic syndromes.
May. 3, 2019—Vanderbilt’s six newest endowed chairs were honored by colleagues, university leaders, family members and donors at a ceremony on April 30 in the Student Life Center.
Aug. 1, 2018—The Howard Hughes Medical Institute has awarded 2018 Gilliam Fellowships for Advanced Study—created to ensure that a diverse and highly trained workforce is prepared to assume leadership roles in the sciences—to three Vanderbilt University doctoral students and their advisers.
Apr. 11, 2018—Vanderbilt investigators have discovered that cancer treatment induces an “idling” state for cells, which could promote resistance to treatment.
Nov. 15, 2017—To develop strategies for preventing radiation-induced lung fibrosis (scarring), Vanderbilt investigators are exploring the cell types and factors that contribute to the fibrotic response.
Oct. 4, 2017—A compound identified at Vanderbilt represents a new lead for treating rare, aggressive childhood cancers called Ewing sarcomas.
Sep. 21, 2017—A research symposium honoring the career of Harold (Hal) Moses, M.D., who founded and served as director emeritus of Vanderbilt-Ingram Cancer Center, has been slated for Wednesday, Oct. 11, 7:45 a.m. – 3:30 p.m., at the Vanderbilt Student Life Center.
Sep. 13, 2017—A research symposium honoring the career of Dr. Hal Moses, Hortense B. Ingram Chair in Cancer Research and professor of cancer biology, is planned for Oct. 11 at the Student Life Center. RSVP to attend the symposium through Oct. 2.
Aug. 9, 2017—New findings could explain the link between chronic stress and reduced survival in women diagnosed with breast cancer, and could lead to new strategies to improve treatment outcomes.
Aug. 8, 2017—Using bioinformatics approaches, Vanderbilt investigators have identified gene expression networks that are deregulated in mouse and human stomach cancers.
Jul. 24, 2017—Vanderbilt University engineers find existing human protein is ideal carrier for powerful molecules that can signal tumors to self-destruct.
Jul. 20, 2017—Signaling through a complex of proteins called mTORC2 plays a role in breast cancer migration, invasion and metastasis, Vanderbilt researchers reported.